Long-Term Monitoring: Beyond the Pain

Because Chronic Nonbacterial Osteomyelitis (CNO) is a chronic condition, the goal of long-term care is to quiet the inflammation and maintain disease control. However, monitoring CNO is unique because how your child feels is only half of the story ^[1].

Clinical vs. Radiological Remission

In CNO, doctors distinguish between two types of remission:

• Clinical Remission: Your child feels no pain, has a normal physical exam, and can participate in all their usual activities ^[1][2].
• Radiological Remission: An MRI shows that the active bone inflammation has resolved and the bone marrow looks healthy again ^[1][3].

It is very common for these two to be “out of sync.” Research has shown that some children in full clinical remission—feeling perfectly well—still have “silent” active lesions visible on a Whole-Body MRI (WB-MRI) ^[1][3]. Because silent inflammation can still cause structural problems over time, routine imaging is often necessary even when your child has no symptoms ^[1][4]. However, clinicians must carefully distinguish active marrow inflammation from residual sclerosis or old vertebral damage; complete disappearance of every MRI abnormality is not necessarily the sole treatment endpoint for every patient.

Long-Term Monitoring Tools

To track your child’s progress objectively, your rheumatology team may use standardized scoring tools. These tools are used by some specialist centers and research programs, though they have limitations:

• CDAS (CNO Clinical Disease Activity Score): This is a clinical tool that combines your child’s pain level, a physician’s assessment, and the number of painful bone sites into a single number ^[2].
• CROMRIS: This is a specialized system radiologists use to score MRI scans ^[5]. It helps them measure exactly how much inflammation is in the marrow and whether it is shrinking over time ^[6][7].

Clinical examination, function, laboratory data, and imaging are interpreted together. A falling score or a persistent MRI abnormality alone does not automatically determine whether treatment should continue or stop.

The Risk of Relapse

CNO is known for “flares” (periods when the disease becomes active again). Relapse is a known risk; for example, one 56-child retrospective cohort found that about 50% relapsed after a median of 2.4 years ^[8]. Because relapse rates vary depending on the case definition, treatment, and follow-up duration, this specific percentage shouldn’t be seen as an exact individual prognosis.

Because of this risk, most specialists recommend long-term follow-up and periodic imaging for several years, even after a child feels well and has stopped taking medication ^[1][4]. Remember that a flare is not automatically permanent damage; it is something the care team can reassess and treat. If pain returns between visits, contact your clinic for guidance.

Potential Long-Term Complications

The main aim of aggressive monitoring is to prevent permanent structural changes to the skeleton. If inflammation is not controlled, it can lead to:

• Vertebral Compression: The bones of the spine (vertebrae) can weaken and lose height. In severe cases with marked flattening, this is called vertebra plana ^[9][1].
• Spinal Deformity: Significant height loss in the vertebrae can lead to kyphosis (a rounded upper back) or scoliosis (an S-shaped curve in the spine) ^[10][9].
• Growth Plate Issues: While less common, if a lesion is located very close to a growth plate (the area where new bone grows), it can potentially cause a limb to grow slightly shorter or at an angle ^[11][12].

While these are recognized potential complications, the expected aim of early and consistent treatment is to significantly reduce these risks ^[13]. By using regular imaging to catch and treat “silent” lesions before they cause permanent damage, most children with CNO can lead healthy, active lives ^[14][1].